1899 related articles for article (PubMed ID: 15609292)
1. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
[TBL] [Abstract][Full Text] [Related]
2. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
3. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
Schweizer C; Reu FJ; Ho AD; Hensel M
Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
[TBL] [Abstract][Full Text] [Related]
4. [Effective treatment with rituximab in a patient with refractory idiopathic thrombocytopenic purpura].
Tanai C; Iki S; Nakahara F; Iijima K; Usuki K; Kuwana M; Urabe A
Rinsho Ketsueki; 2004 Nov; 45(11):1181-6. PubMed ID: 15609684
[TBL] [Abstract][Full Text] [Related]
5. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
[TBL] [Abstract][Full Text] [Related]
6. Membranous nephropathy and thrombotic thrombocytopenic purpura treated with rituximab.
Kuppachi S; Chander P; Yoo J
J Nephrol; 2009; 22(4):561-4. PubMed ID: 19662613
[TBL] [Abstract][Full Text] [Related]
7. Anti-CD20 antibody in thrombotic thrombocytopenic purpura refractory to plasma exchange.
Chow KV; Carroll R; Branley P; Nicholls K; Becker G; Hogan C
Intern Med J; 2007 May; 37(5):329-32. PubMed ID: 17504282
[TBL] [Abstract][Full Text] [Related]
8. Rituximab in the treatment of relapsing idiopathic thrombocytopenic purpura.
Riksen NP; Keuning JJ; Vreugdenhil G
Neth J Med; 2003 Jul; 61(7):262-5. PubMed ID: 14567524
[TBL] [Abstract][Full Text] [Related]
9. Rituximab in the treatment of relapsed thrombotic thrombocytopenic purpura.
Reddy PS; Deauna-Limayo D; Cook JD; Ganguly SS; Blecke C; Bodensteiner DC; Skikne BS; Sahud MA
Ann Hematol; 2005 Apr; 84(4):232-5. PubMed ID: 15517266
[TBL] [Abstract][Full Text] [Related]
10. [Idiopathic thrombocytopenic purpura associated with mantle cell lymphoma showing an increase in the platelet count receiving anti-CD20 antibody rituximab].
Kawachi Y; Ide M; Uchida T; Setsu K
Rinsho Ketsueki; 2003 Jan; 44(1):31-3. PubMed ID: 12649836
[TBL] [Abstract][Full Text] [Related]
11. The role of autoantibody-producing plasma cells in immune thrombocytopenic purpura refractory to rituximab.
Kuwana M; Iki S; Urabe A
Am J Hematol; 2007 Sep; 82(9):846-8. PubMed ID: 17506067
[TBL] [Abstract][Full Text] [Related]
12. Successful repeat therapy with rituximab for relapsed thrombotic thrombocytopenic purpura.
Patino W; Sarode R
J Clin Apher; 2007 Feb; 22(1):17-20. PubMed ID: 17285618
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura.
Cooper N; Stasi R; Cunningham-Rundles S; Feuerstein MA; Leonard JP; Amadori S; Bussel JB
Br J Haematol; 2004 Apr; 125(2):232-9. PubMed ID: 15059147
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature.
Santos ES; Arosemena LR; Raez LE; O'Brien C; Regev A
Liver Int; 2006 Jun; 26(5):625-9. PubMed ID: 16762009
[TBL] [Abstract][Full Text] [Related]
15. Cardiogenic shock complicates successful treatment of refractory thrombotic thrombocytopenia purpura with rituximab.
Millward PM; Bandarenko N; Chang PP; Stagg KF; Afenyi-Annan A; Hay SN; Brecher ME
Transfusion; 2005 Sep; 45(9):1481-6. PubMed ID: 16131381
[TBL] [Abstract][Full Text] [Related]
16. Chronic refractory idiopathic thrombocytopenic purpura (ITP) and anti-CD20 monoclonal antibody: a case report.
Latifzadeh SZ; Entezari V
Clin Appl Thromb Hemost; 2006 Oct; 12(4):489-92. PubMed ID: 17000895
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab.
Chemnitz J; Draube A; Scheid C; Staib P; Schulz A; Diehl V; Söhngen D
Am J Hematol; 2002 Oct; 71(2):105-8. PubMed ID: 12353309
[TBL] [Abstract][Full Text] [Related]
18. Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients.
Peñalver FJ; Jiménez-Yuste V; Almagro M; Alvarez-Larrán A; Rodríguez L; Casado M; Gallur L; Giraldo P; Hernández R; Menor D; Rodríguez MJ; Caballero D; González R; Mayans J; Millán I; Cabrera JR;
Ann Hematol; 2006 Jun; 85(6):400-6. PubMed ID: 16550390
[TBL] [Abstract][Full Text] [Related]
19. A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia.
Saleh MN; Gutheil J; Moore M; Bunch PW; Butler J; Kunkel L; Grillo-López AJ; LoBuglio AF
Semin Oncol; 2000 Dec; 27(6 Suppl 12):99-103. PubMed ID: 11226008
[TBL] [Abstract][Full Text] [Related]
20. [Rituximab treatment for adults with steroid-resistant idiopathic thrombocytopenic purpura].
Wang W; Yu QH; Zhang HY; Chu XX; Chen F; Zhang CQ; Zhou YH; Hou M
Zhonghua Nei Ke Za Zhi; 2008 Mar; 47(3):225-7. PubMed ID: 18785508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]